J07AH08
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
Наименование на групата: WHO Collaborating Centre for Drug Statistics Methodology
Лекарствени продукти в тази категория
3 продукта в тази категория и подгрупите ѝ.
| Търговско име | Концентрация |
|---|---|
| MenQuadfi | --¹ One dose 0.5 mL contains: Neisseria meningitidis group A polysaccharide² 10 micrograms Neisseria meningitidis group C polysaccharide² 10 micrograms Neisseria meningitidis group Y polysaccharide² 10 micrograms Neisseria meningitidis group W polysaccharide² 10 micrograms ²Conjugated to tetanus toxoid carrier protein 55 micrograms |
| Menveo | --¹ One dose (0.5 ml) contains: Meningococcal group A oligosaccharide 10 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 16.7 to 33.3 micrograms Meningococcal group C oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 7.1 to 12.5 micrograms Meningococcal group W135 oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 3.3 to 8.3 micrograms Meningococcal group Y oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 5.6 to 10.0 micrograms |
| Nimenrix | --¹ Neisseria meningitidis serogroup A polysaccharide* 5 micrograms Neisseria meningitidis serogroup C polysaccharide* 5 micrograms Neisseria meningitidis serogroup W-135 polysaccharide* 5 micrograms Neisseria meningitidis serogroup Y polysaccharide* 5 micrograms *conjugated to tetanus toxoid carrier protein 44 micrograms |